Stay updated on Nasal Polyposis Dose Study Clinical Trial
Sign up to get notified when there's something new on the Nasal Polyposis Dose Study Clinical Trial page.

Latest updates to the Nasal Polyposis Dose Study Clinical Trial page
- CheckyesterdayNo Change Detected
- Check9 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.1%
- Check16 days agoNo Change Detected
- Check23 days agoChange DetectedThe page has removed significant details about a Phase 2 study on AK001 for nasal polyposis, including the study's purpose, inclusion and exclusion criteria, and the principal investigator's name. A new revision number has been added.SummaryDifference12%
- Check30 days agoChange DetectedThe web page has been updated to version 2.14.4, replacing the previous version 2.14.3.SummaryDifference0.1%
- Check38 days agoChange DetectedThe web page has been updated from version 2.14.2 to version 2.14.3.SummaryDifference0.1%
- Check66 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference2%
- Check88 days agoChange DetectedThe page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with a contact email for assistance.SummaryDifference2%
Stay in the know with updates to Nasal Polyposis Dose Study Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nasal Polyposis Dose Study Clinical Trial page.